Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Mohamed A. Adam, Amer H. Zureikat, Stacy J. Kowalsky, Ibrahim Nassour, Alessandro Paniccia, Aatur D. Singhi, Nathan Bahary, Kenneth K.W. Lee, Samer Al Masri
Publikováno v:
Journal of surgical oncologyREFERENCES. 123(1)
BACKGROUND There are limited data on the efficacy of neoadjuvant therapy (NAT) for early-stage distal pancreas adenocarcinoma (PDAC). Previous studies focused on adenocarcinoma of the head of the pancreas or dealt with borderline and locally advanced
Autor:
Kenneth K. Lee, Samer Tohme, Mohamed A. Adam, Alessandro Paniccia, Sharon Winters, David L. Bartlett, Ibrahim Nassour, Richard S. Hoehn, Amer H. Zureikat
Publikováno v:
Journal of surgical oncologyREFERENCES. 122(2)
Background Robotic pancreatectomy is gaining momentum; however, limited data exist on the long-term survival of this approach for pancreatic ductal adenocarcinoma (PDAC). The objective of this study is to compare the long-term oncologic outcomes of r
Autor:
Virginia Falvello, Nathan Bahary, Herbert J. Zeh, Amer H. Zureikat, Ashika Mani, Mazen S. Zenati, Amr I. Al Abbas, Aatur D. Singhi, Melissa E. Hogg
Publikováno v:
Journal of surgical oncologyREFERENCES.
BACKGROUND AND OBJECTIVES Ampullary adenocarcinoma (AA) is classified by immunohistochemical (IHC) subtypes into intestinal (IN), pancreatobiliary (PB), and ambiguous (AM). The impact of adjuvant therapy on IHC subtype and disease stage is unclear. W